Oric Pharmaceuticals, Inc. Common Stock (ORIC) Stock Price

ORICStock
$13.83+38.19%52W
Market Cap$1.43B
P/E
PEG Ratio
Div yield
Beta0.95

ORIC Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)13.04%
Price vs S&P 500 (4W)9.96%
VGM Score69.47

ORIC Earnings Surprise History

Q2 25-0.47est. -0.44
Q3 25-0.33est. -0.40
Q4 25-0.30est. -0.37
Q1 26-0.34est. -0.32
Q2 26-0.38est. -0.36

ORIC Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.33
4.32
4.32
4.33

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
ORICOric Pharmaceuticals, Inc. Common Stock
B$13.83
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Oric Pharmaceuticals, Inc. Common Stock

ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies designed to overcome cancer resistance mechanisms across three focus areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company's pipeline includes product candidates ORIC-944, ORIC-114, and ORIC-533.